Christine Brennan

Directeur/Membre du Conseil chez BOUNDLESS BIO, INC.

Profil

Christine Brennan is currently the Managing Director at Vertex Ventures HC, an Independent Director at Boundless Bio, Inc., a Director at Tallac Therapeutics, Inc., an Investment Committee Member at Pathway To Cures, and a Board Member at Redona Therapeutics, Inc. She previously worked as the Executive Director, Head-Strategy & Operations at Novartis Institutes for Biomedical Research, Inc., a Director at Altimmune, Inc., the Director of Business Development at FORUM Pharmaceuticals, Inc., a Director at Alector, Inc., the Director of Therini Bio, Inc., a Director at Impresa Management LLC, a Director at Entrada Therapeutics, Inc., a Partner at Merck Research Ventures, a Principal at Novartis Venture Funds (USA), and the Chief Business Officer at Vitae Pharmaceuticals LLC.
She also worked as a Scientific Analyst at Cogent Neuroscience, Inc., a Senior Consultant at Kendall Strategies, Inc., and a Product Manager-Cardizem LA at Biovail Corp.
Dr. Brennan received her undergraduate degree from the University of New Hampshire and her doctorate from Dartmouth Medical School.

Postes actifs de Christine Brennan

Sociétés	Poste	Début
BOUNDLESS BIO, INC.	Directeur/Membre du Conseil	01/02/2022
Tallac Therapeutics, Inc.	Directeur/Membre du Conseil	-
Redona Therapeutics, Inc.	Directeur/Membre du Conseil	-
Pathway To Cures	Membre du Comité d'Investissement	27/02/2023
Vertex Ventures HC	Private Equity Investor	17/02/2022

Anciens postes connus de Christine Brennan

Sociétés	Poste	Fin
Merck Research Ventures	Private Equity Investor	01/02/2022
Therini Bio, Inc.	Directeur/Membre du Conseil	01/01/2021
Novartis Venture Funds (USA)	Private Equity Investor	31/05/2017
VITAE PHARMACEUTICALS INC	Corporate Officer/Principal	01/11/2013
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░

Formation de Christine Brennan

Dartmouth Medical School	Doctorate Degree
University of New Hampshire	Undergraduate Degree